[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
September 1997

Latanoprost and Hyperpigmentation of Eyelashes

Arch Ophthalmol. 1997;115(9):1206-1208. doi:10.1001/archopht.1997.01100160376025

Latanoprost (Xalatan, Pharmacia Upjohn Co, Kalamazoo, Mich) is the first new class of antiglaucoma medication introduced in 20 years. Initial reports about its ocular hypotensive effects seem to be promising, but it has an intriguing side effect of increasing iris pigmentation. On a theoretical basis, hyperpigmentation of periocular structures also